Codexis Company Description

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.

It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Codexis, Inc.

Country	United States
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	188
CEO	Stephen Dilly

Contact Details

Address: 200 Penobscot Drive Redwood City, Delaware 94063 United States
Phone	650 421 8100
Website	codexis.com

Stock Details

Ticker Symbol	0I0X
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US1920051067
SIC Code	2836

Key Executives

Name	Position
Dr. Stephen George Dilly MBBS, Ph.D.	President, Chief Executive Officer and Chairman
Georgia L. Erbez	Chief Financial Officer
Kevin Norrett M.B.A., M.S.	Chief Operating Officer
Dr. Alison Moore Ph.D.	Chief Technology Officer and Executive Vice President
Senator Byron L. Dorgan M.B.A.	Consultant
Carrie McKim	Director of Investor Relations
Karen Frechou-Armijo	Senior Vice President and Head of Human Resources
Dr. Stefan Lutz Ph.D.	Senior Vice President of Research
John Schiffhauer	Senior Vice President of Intellectual Property